Ipamorelin is a synthetic peptide classified as a selective growth-hormone secretagogue. It is studied for stimulating the pituitary gland to release the body's own growth hormone via the ghrelin-receptor pathway.

What does research suggest about Ipamorelin?

Preclinical studies have documented growth-hormone-release effects, and there is some early clinical study history. However, human evidence is limited and many claims about its benefits go beyond what controlled trials have demonstrated.

Is Ipamorelin approved or legal?

Ipamorelin is not an approved medicine for general use and holds a research-chemical status. It has not been validated or authorized as a therapy for any condition.

Its long-term safety profile in humans is not well established. Because it affects the hormonal system, any effects carry real risks, and anything hormonal warrants qualified professional supervision.

What are the reported side effects of Ipamorelin?

Side effects discussed in connection with growth-hormone secretagogues include water retention and headache. The full long-term side-effect profile in humans remains poorly characterized.

Why is Ipamorelin often mentioned with CJC-1295?

Both are growth-hormone secretagogues frequently discussed together in the context of the growth-hormone axis, recovery and sleep. Neither is an approved therapy, and combining hormonal compounds adds further uncertainty.

Why is ipamorelin so often mentioned together with CJC-1295?

They act on different parts of the same growth-hormone pathway, so hobbyist and research discussions frequently pair them. Being commonly stacked in online conversation is not evidence of safety or effectiveness; neither is an approved therapy, and combining hormonal compounds can compound unknown risks rather than validate them.

Is ipamorelin the same thing as taking growth hormone?

No, and treating them as interchangeable is a common misconception. Ipamorelin is a secretagogue meant to prod the body's own growth-hormone release, whereas HGH is the hormone itself. The distinction matters biologically, but it does not make ipamorelin a proven or approved alternative.

Why does ipamorelin remain popular despite thin human evidence?

Its appeal is largely driven by its reputation for being 'selective' in early animal work and by heavy online discussion, not by robust clinical outcomes. Popularity and marketing visibility are not the same as demonstrated efficacy or an established long-term safety record.

Where can I buy Ipamorelin and compare vendors?

Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Growth Hormone Secretagogue

Buy Ipamorelin – Vendors, Prices, Testing and Evidence

Buy Ipamorelin

Also known as: Growth hormone secretagogue

Evidence grade C — Early / PreclinicalRisk flag

Short answer

A growth-hormone secretagogue discussed for recovery and body composition. Limited human trial evidence.

Where can you buy Ipamorelin?

Crystal Peptides. The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

What is known?

Ipamorelin is a selective growth-hormone secretagogue peptide.

What is not established?

Some early clinical study history; not an approved therapy.

Safety

Hormonal effects carry real risks; not a validated therapy. Professional supervision matters for anything hormonal.

Regulatory status

Not an approved medicine for general use. Research chemical status.

Not medical advice. This educational reference is not diagnosis, treatment, prescribing, dosing or emergency guidance. Consult a qualified professional before making health-related decisions.

Regulatory or safety concern: This substance may be unapproved for human use, affect the hormonal system, or be subject to regulator or anti-doping restrictions. Check the cited evidence and rules in your jurisdiction.

Vendor comparison

Buy Ipamorelin: compare vendors

The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

Vendor	Product	Documentation	Shipping	Checked	Action
Crystal Peptides Code PEPTIDES10 −10% · discount code details Sponsored	Ipamorelin research product	Vendor-supplied data COA stated as available Not independently documented	Europe See the localized country store	Jul 18, 2026	View at vendor

Crystal Peptides

Ipamorelin research product

Code PEPTIDES10 −10% · discount code details

What is it?

Ipamorelin is a selective growth-hormone secretagogue peptide.

Research and evidence

Ipamorelin is a synthetic peptide classified as a selective growth-hormone secretagogue, meaning it is studied for its ability to prompt the pituitary gland to release the body's own growth hormone. It acts through the ghrelin-receptor pathway rather than by supplying growth hormone directly, and among the older secretagogues it is often described in the research literature as comparatively selective for stimulating growth-hormone release. Within peptide communities it is frequently discussed alongside CJC-1295 in the context of recovery, sleep and body composition. It is important to state plainly what Ipamorelin is not: it is not an approved medicine for general use, and it exists in a research-chemical status rather than as a validated therapy.

The scientific interest in Ipamorelin stems from early pharmacological work characterizing how it triggers growth-hormone secretion. Preclinical studies documented measurable growth-hormone-release effects, and there is some early clinical study history from its investigational period. However, the human evidence base is limited and Ipamorelin did not advance to become an approved therapeutic. Much of what circulates online about its benefits for muscle, fat loss or anti-aging extends well beyond what controlled human trials have actually demonstrated. The honest evidence picture is that mechanistic and animal data exist, human data are sparse, and long-term outcome data in people are lacking.

Because Ipamorelin acts on the hormonal system, any physiological effects it produces carry real considerations. Manipulating the growth-hormone axis is not trivial, and the peptide's long-term safety profile in humans is not well established. Reported side effects discussed in connection with growth-hormone secretagogues include water retention and headache. This page is an educational reference intended to help readers understand what Ipamorelin is, why it has been researched, and where the evidence remains preliminary. It is not medical advice, and anything involving hormonal compounds warrants qualified professional oversight.

Evidence grade: C

Some early clinical study history; not an approved therapy. Preclinical GH-release effects documented.

Human evidence

Some early clinical study history; not an approved therapy.

Animal and preclinical evidence

Preclinical GH-release effects documented.

Proposed mechanisms

Stimulation of growth-hormone release via ghrelin-receptor pathways

Safety concerns and known side effects

Hormonal effects carry real risks; not a validated therapy. Professional supervision matters for anything hormonal.

Water retention reported
Headache reported

Regulatory status

Not an approved medicine for general use. Research chemical status.

Ipamorelin research timeline

Late 1990s
First described in the scientific literature by pharmaceutical researchers as a selective growth-hormone secretagogue that raised GH without strongly affecting cortisol or prolactin.
Late 1990s–2000s
Preclinical work in animals characterized its GH-releasing action through ghrelin-receptor pathways, establishing the mechanism now cited in most references.
2000s
Explored in early-stage clinical settings as a potential drug candidate, but development did not advance to marketing approval and human trial data remained limited and dated.
2010s
With no approved medical product, the peptide circulated widely as a 'research chemical' sold for laboratory use only, frequently discussed alongside CJC-1295.
Early 2020s
U.S. regulators moved to restrict growth-hormone secretagogue peptides in compounding pharmacies, reflecting unresolved safety and quality concerns; ipamorelin remains not approved as a medicine for general use.

Frequently asked questions about Ipamorelin

What is Ipamorelin?: Ipamorelin is a synthetic peptide classified as a selective growth-hormone secretagogue. It is studied for stimulating the pituitary gland to release the body's own growth hormone via the ghrelin-receptor pathway.
What does research suggest about Ipamorelin?: Preclinical studies have documented growth-hormone-release effects, and there is some early clinical study history. However, human evidence is limited and many claims about its benefits go beyond what controlled trials have demonstrated.
Is Ipamorelin approved or legal?: Ipamorelin is not an approved medicine for general use and holds a research-chemical status. It has not been validated or authorized as a therapy for any condition.
Is Ipamorelin safe?: Its long-term safety profile in humans is not well established. Because it affects the hormonal system, any effects carry real risks, and anything hormonal warrants qualified professional supervision.
What are the reported side effects of Ipamorelin?: Side effects discussed in connection with growth-hormone secretagogues include water retention and headache. The full long-term side-effect profile in humans remains poorly characterized.
Why is Ipamorelin often mentioned with CJC-1295?: Both are growth-hormone secretagogues frequently discussed together in the context of the growth-hormone axis, recovery and sleep. Neither is an approved therapy, and combining hormonal compounds adds further uncertainty.
Why is ipamorelin so often mentioned together with CJC-1295?: They act on different parts of the same growth-hormone pathway, so hobbyist and research discussions frequently pair them. Being commonly stacked in online conversation is not evidence of safety or effectiveness; neither is an approved therapy, and combining hormonal compounds can compound unknown risks rather than validate them.
Is ipamorelin the same thing as taking growth hormone?: No, and treating them as interchangeable is a common misconception. Ipamorelin is a secretagogue meant to prod the body's own growth-hormone release, whereas HGH is the hormone itself. The distinction matters biologically, but it does not make ipamorelin a proven or approved alternative.
Why does ipamorelin remain popular despite thin human evidence?: Its appeal is largely driven by its reputation for being 'selective' in early animal work and by heavy online discussion, not by robust clinical outcomes. Popularity and marketing visibility are not the same as demonstrated efficacy or an established long-term safety record.
Where can I buy Ipamorelin and compare vendors?: Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Common discussion areas

RecoverySleepStacking with CJC-1295

Compare Ipamorelin

Ipamorelin vs CJC-1295

Sources

Growth hormone secretagogues: history, mechanism of action, and clinical development — JCSM Rapid Communications (Wiley)

Editorial review and transparency

Written by: peptides.cx Editorial Team
Scientific reviewer: No named medical reviewer is currently assigned
Last editorial review: June 1, 2026
Last vendor check: July 18, 2026
Review method: Source review, claim verification, vendor-data separation and regulatory-context review.
Commercial disclosure and conflicts: Vendor relationships do not determine evidence or safety ratings. No named reviewer conflict is recorded because no named reviewer is assigned.

Editorial policy →Evidence grade →Vendor methodology →

Related on peptides.cx

Library →Vendor quality checklist →Safety →Affiliate code: PEPTIDES10